| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.00095 | 1 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.00091 | 1 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.0009 | 1 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.00062 | 1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0006 | 1 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.00059 | 1 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.00082 | 1 |